Literature DB >> 17419743

Bone changes in myelofibrosis with myeloid metaplasia: a histomorphometric and microcomputed tomographic study.

Aline Schmidt1, Odile Blanchet, Mamoun Dib, Michel F Baslé, Norbert Ifrah, Daniel Chappard.   

Abstract

Myelofibrosis with myeloid metaplasia (MMM) is a clonal disorder of the haematopoietic stem cell which can be associated with marrow fibrosis and/or osteosclerosis. Because bone progenitors and mature bone cells are influenced by the marrow microenvironment, cellular and tissular changes were assessed by histomorphometry in MMM. Thirteen patients, with a clinical proven MMM, had a bone biopsy of the iliac crest with double tetracycline labelling and osteoclast count. Histomorphometry was done at the 2D level (bone volume, osteoid parameters, bone histodynamic parameters and osteoclast count) and 3D level by microcomputed tomography. All patients had clusters of abnormal megakaryocytes in bone marrow. Newly apposed bone packets were observed in 12 patients and corresponded to an increased thickness of some bone units with new lamellae or focal areas of woven bone anchored on the pre-existing trabeculae. Osteoid parameters were unchanged, only bone formation rate appeared considerably increased in seven patients. There was a net tendency for decrease in osteoclast number and conversion of trabecular pillars into plates. An uncoupling of bone remodelling was evidenced with an increased life-span of osteoblasts associated with a normal/reduced osteoclast activity. A very complex network of factors is candidate to explain bone changes observed in MMM.

Entities:  

Mesh:

Year:  2007        PMID: 17419743     DOI: 10.1111/j.1600-0609.2007.00852.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  7 in total

1.  Myelofibrosis osteoclasts are clonal and functionally impaired.

Authors:  Ivo Veletic; Taghi Manshouri; Asha S Multani; C Cameron Yin; Lei Chen; Srdan Verstovsek; Zeev Estrov
Journal:  Blood       Date:  2019-02-11       Impact factor: 22.113

2.  Aging negatively impacts the ability of megakaryocytes to stimulate osteoblast proliferation and bone mass.

Authors:  Kevin A Maupin; Evan R Himes; Artur P Plett; Hui Lin Chua; Pratibha Singh; Joydeep Ghosh; Safa F Mohamad; Irushi Abeysekera; Alexa Fisher; Carol Sampson; Jung-Min Hong; Paul Childress; Marta Alvarez; Edward F Srour; Angela Bruzzaniti; Louis M Pelus; Christie M Orschell; Melissa A Kacena
Journal:  Bone       Date:  2019-07-09       Impact factor: 4.398

3.  Role of Endothelin-1 in a Syndrome of Myelofibrosis and Osteosclerosis.

Authors:  Ralph Yachoui; Jasmin Kristianto; Kajal Sitwala; Robert D Blank
Journal:  J Clin Endocrinol Metab       Date:  2015-09-10       Impact factor: 5.958

4.  Lipocalin produced by myelofibrosis cells affects the fate of both hematopoietic and marrow microenvironmental cells.

Authors:  Min Lu; Lijuan Xia; Yen-Chun Liu; Tsivia Hochman; Laetizia Bizzari; Daniel Aruch; Jane Lew; Rona Weinberg; Judith D Goldberg; Ronald Hoffman
Journal:  Blood       Date:  2015-05-28       Impact factor: 22.113

Review 5.  Megakaryocyte pathology and bone marrow fibrosis: the lysyl oxidase connection.

Authors:  Nikolaos Papadantonakis; Shinobu Matsuura; Katya Ravid
Journal:  Blood       Date:  2012-07-05       Impact factor: 22.113

Review 6.  Myeloproliferative disorders and their effects on bone homeostasis: the role of megakaryocytes.

Authors:  Aikaterini Karagianni; Katya Ravid
Journal:  Blood       Date:  2022-05-26       Impact factor: 25.476

7.  Quantification of dendritic cells and osteoclasts in the bone marrow of patients with monoclonal gammopathy.

Authors:  Nicolas Josselin; Hélène Libouban; Mamoun Dib; Norbert Ifrah; Erick Legrand; Michel Félix Baslé; Maurice Audran; Daniel Chappard
Journal:  Pathol Oncol Res       Date:  2008-08-28       Impact factor: 3.201

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.